ABSTRACT
Transfusions are one of the most common procedures performed in hospitals, 1 yet the frequent adverse events of transfusion are often not recognized. These adverse events include transfusion-related acute lung injury, transfusion-associated graft-versus-host disease, transfusion-associated circulatory overload, immunomodulation, inflammation, nosocomial infection, and thrombosis. 2, 3 While some of these adverse effects are quite rare, others are likely more common but difficult to identify.
Transfusion of RBCs and/or platelets is associated, in a dose-dependent fashion, with high morbidity and mortality rates. [4] [5] [6] [7] [8] It is possible that this observation is related to confounding by differential severity of illness of recipients and acute blood loss. However, mounting evidence indicates that there is direct toxicity from these transfusions, stemming from degradation of these products during storage, known as the "storage lesion," [9] [10] [11] and the allogeneic nature (immunologic incompatibility) of the cells and plasma. In a systematic literature review, prolonged RBC storage was found to be associated with adverse clinical outcomes, including mortality and organ failure, based on strong laboratory evidence and observational studies. 12 It is uncertain whether this association is related to hemolysis or other storage-induced lesions, and it has not been mitigated by transfusion of shorter-storage RBCs in randomized trials. Some of the deleterious effects appear to be mitigated by modifications such as leukoreduction 3, 13 and/or saline washing 14, 15 or avoided by use of autologous transfusions 16 and restrictive transfusion practices. 17, 18 Pretransfusion washing of stored RBC and platelet units is an accepted and valuable therapeutic option for patients with repeated and/or severe allergic or febrile transfusion reactions. Recent data from randomized and observational clinical trials demonstrate that pretransfusion washing reduces inflammatory and immunologic complications, including recurrence of acute leukemia, 15 elevations of interleukin-6 and C-reactive protein after pediatric cardiac surgery, 14 transfusion-related acute lung injury, and transfusion-associated circulatory overload. 13 However, washing of RBCs may not be completely benign. Increased hemolysis may occur in vitro during the washing process, and this may be particularly important for RBCs of longer storage duration, which was associated with a higher complication rate in post hoc analysis of a randomized trial. 14, 19, 20 Suboptimal platelet function has also been observed in washed platelets. 21 Cholette et al 14 demonstrated increased morbidity in children following cardiac surgery with cardiopulmonary bypass who received washed RBCs that were previously stored for more than 28 days compared to less than 14 days. This important finding suggests that the benefit of washed RBC transfusions may vary depending on the storage duration prior to washing.
Current washing techniques and dilution of RBCs and platelets for transfusion employ normal saline (NS; 0.9% sodium chloride, NaCl). Data analysis of transfusions at our medical center in 2016 reveal that we transfused about 4,600 platelet doses, of which 27% were NS-washed platelets, and about 15,000 RBC, of which 12% were NS-washed RBCs. Our washing protocol is indicated for patients with documented IgA deficiency, history of severe allergic transfusion reaction, hematologic malignancies, intrauterine transfusions, newborns, neonatal alloimmune thrombocytopenic purpura, priming the extracorporeal membrane oxygenation circuit for infants younger than 1 year of age, neonates with positive circulating maternal isoagglutinin (anti-A/B) testing, patients expressing polyagglutination, liver transplant (two RBC units for initial cooler), pediatric cardiac surgery cases on cardiopulmonary bypass and 5 years old or younger (first RBC unit washed), and for intrauterine and neonatal exchange transfusions. We evaluated whether washing cellular blood components with a more physiologic solution, Plasma-Lyte A (PL-A), might cause less damage to RBCs and better preserve platelet function as compared with NS.
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Materials and Methods
Washing Solution Compositions
Normal Saline
NS is an isotonic 0.9% NaCl solution that is composed of 154 mEq/L Na + and 154 mEq/L Cl -(354.2 mg/dL Na + and 546.7 mg/dL Cl -) with a neutral pH of 7. However, data showed that the actual pH of NS preparations for infusion is acidic (pH of 5.5-6) at ambient temperature. The acidity of NS is claimed to be due to the plastic pouch container, which is typically composed of polyvinylchloride. 24 
Plasma-Lyte
Washed Red Blood Cells
RBC units (n = 14) were procured randomly from the blood bank at Strong Memorial Hospital/University of Rochester Medical Center. A prewash sample (12 mL) was collected from each RBC unit as a baseline using a syringe and needle-free sampling site coupler. The prewash hemoglobin and hematocrit were tested using a Sysmex KX-21N cell counter (Sysmex America, Mundelein, IL). Each RBC unit (10 AS-1, 3 AS-3, and 1 CPD-A1) was divided into two equal parts (150 ± 10 mL) using aseptic technique into a 600-mL Blood Transfer Unit Pack with piercing pin (Charter Medical, Winston-Salem, NC). Each half RBC unit was then washed employing a routine clinical protocol on a COBE 2991 Blood Cell 
Processor (Terumo, Lakewood, CO) 26 with 1 L of either NS or PL-A as a wash solution. After the wash solution was added to the RBCs, in an open system method that allows storage for up to 24 hours, a supernatant consisting of the wash solution, plasma proteins, and anticoagulant/ preservative was separated from the RBCs by centrifugation. The supernatant was then expressed into a waste bag. The process was repeated for a total of three washing cycles. Once removed from the blood processor, the washed RBCs were resuspended with 20 mL of the wash solution with the syringe and needle-free sampling site coupler. Final volumes and hematocrits for NS and PL-A averaged 87.0 ± 16.4 mL, 61.1%, and 86.7 ± 14.6 mL, 58.8%, respectively. Washed RBCs were maintained at 1°C to 6°C. Samples (12 mL each) were collected from each washed product immediately after washing/resuspending, and at 24, 48, and 72 hours post washing.
Cell counts were performed at each time point using a Sysmex KX-21N analyzer. Samples were then immediately centrifuged in a Sorvall RC-3 centrifuge (Beckman Coulter, Carlsbad, CA) for 15 minutes at 4300g. Supernatants were dispensed into labeled cryovials and frozen at -80°C until further testing. Quantification of free heme and free hemoglobin in supernatants was performed using QuantiChrom Assay Kits (Bioassay Systems, Hayward, CA) as previously described.
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Washed Platelets
Platelet-rich plasma (PRP) samples were prepared from whole blood and aliquoted (3 mL) from clinical grade platelet concentrates (PC) units (storage period of 5 days) as prepared for transfusion (n = 21). Samples were then washed via an in vitro tube model similar to our standard clinical washing protocol for the COBE 2991. 28 Briefly, samples were centrifuged for 10 minutes at 1200g, resuspended in 4.5 mL of either NS or PL-A solution, centrifuged again, and resuspended in 3 mL of the corresponding wash solution (n = 13) or ABO-identical fresh plasma (n = 8).
Platelet aggregation studies were performed with light transmission aggregometry on PRP samples (average platelet count 255 ± 27 × 10 9 /L) as per manufacturer's instructions on a lumiaggregometer (560VS, Chrono-Log Corporation, Havertown, PA) as previously described. 29 Adenosine diphosphate (ADP, 10 µmol/L), epinephrine (10 µmol/L), and collagen (2 µg/mL) agonists (Chronolog Corporation) were added simultaneously to induce platelet aggregation. ADP and epinephrine were added at time 0 followed by collagen at 10 minutes. Platelet aggregations were then quantified over 20 minutes.
Washed Platelet Spreading Assay
To test the effects of washing and washing fluids on platelet spreading, which is an indication of platelet adherence function, four additional stored PC samples (storage length of 5 days) and four fresh platelet-rich plasma sample controls were washed and spread on fibrinogen-coated coverslips as previously described. 29 Briefly, fresh whole blood samples were collected in 3.2% sodium citrate vacutainer tubes from healthy donors who were free of platelet inhibiting medications. Samples were processed immediately and 3 mL of PRP was isolated through centrifugation (10 minutes at 160g). Samples were then washed as described above with either NS or PL-A. Stored PC samples were obtained and washed as described above in both solutions. Platelets were diluted to a final concentration of 33 × 10 9 platelets/L with respective washing solutions. The platelets were then incubated at 37°C for 45 minutes on glass coverslips that had been coated with 0.25 mg/mL fibrinogen for 2 hours and blocked with 0.5% bovine serum albumin. Unbound platelets were washed away from coverslips with phosphate-buffered saline (PBS) and bound platelets were fixed with 4% paraformaldehyde for 15 minutes and again washed with PBS before being mounted onto glass slides. Platelet spreading was visualized by light microscopy (Zeiss Axiovert 200, Carl Zeiss, Thornwood, NY) and three or four fields were photographed. Platelets were counted and categorized based on their level of spreading by a single technician blinded to the washing solution. Platelets were categorized as (1) not spread if they lacked filopodia, (2) partially spread if they had filopodia but lacked lamellipodia, and (3) fully spread if they demonstrated lamellipodia.
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Statistical Analysis
Data are reported as means ± standard error of the mean (SEM) in RBC experiments. Comparisons were performed between RBCs washed with NS vs PL-A using Wilcoxon signed-rank test. Data of the free hemoglobin concentrations of shorter-and longer-storage RBC washed with either NS or PL-A are reported as means ± standard deviation (SD) and the two-tailed Student t tests is used for comparisons. Means ± SD is also used in platelet experiments. Platelet aggregation of platelets washed in NS and PL-A were compared for resuspension with either the washing solution or ABOidentical plasma using two-tailed Student t tests. t tests were also used for platelet spreading experiments where fresh platelet were added to both washing solutions for direct comparisons. A P value of ≤.05 was considered statistically significant.
Results
Washing With Plasma-Lyte A Leads to Reduced Hemolysis Compared With Normal Saline
The median storage age of RBC units was 19 days (range, 10-39 days). The mean ± SEM prewashed hemoglobin and hematocrit were 19.3 ± 0.41 mg/dL and 58.8% ± 1.02%, respectively. Immediately before and after washing, RBC supernatants from both arms had similar mean free hemoglobin and heme ❚Figure 1❚. Washing reduced both free hemoglobin and free heme by about 37% in NS and 43% in PL-A group, respectively: free hemoglobin (mg/dL) prewash 83.7 ± 15, NS postwash 54 ± 3.5, PL-A postwash 48 ± 3.7 (P = .07); free heme (µmol/L) prewash 46 ± 8.4, NS postwash 29 ± 1.7, PL-A postwash 26 ± 2.2 (P = .28) (Figure 1) .
However, by 24 hours of storage at 1°C to 6°C after washing (the current limit for clinical use in an open system such as the COBE 2991 cell washer), supernatant free hemoglobin and heme levels were significantly increased in RBCs stored in NS as compared to PL-A: free hemoglobin (mg/dL): NS 114 ± 11, PL-A 74 ± 5.7 (109% increase; P < .001); free heme (µmol/L): NS 63 ± 6.1, PL-A 41 ± 3.5 (117% increase; P < .001). These differences between use of NS and PL-A increased over storage time, indicating that prolonged storage after NS washing predisposed to greater hemolysis than PL-A washing (Figure 1 ).
Plasma-Lyte A Mitigates Hemolysis After Washing of Longer Storage Duration RBCs
Substantial differences were detected in the free hemoglobin and free heme levels between the shorter-storage RBC units (n = 5; mean storage duration, 14.2 ± 3 days) and longer-storage RBC units (n = 4; mean storage duration, 34 ± 3.8 days, P < .001). Although not statistically significant, the average baseline (before washing) levels of free hemoglobin and free heme were 86% and 99% higher in the longer-storage RBC units than the shorter-storage RBC (free hemoglobin 132 mg/dL vs 71 mg/dL; free heme 75 μmol/L vs 38 μmol/L, respectively) ❚Table 2❚ and ❚Table 3❚. No significant changes in the free heme were observed between the shorter-storage and longer-storage RBC units immediately after washing with either NS or PL-A (Table 3) . However, a significant increase (P = .025) in the free hemoglobin was observed in the NS-washed longer-storage RBC ( Table 2 ). Substantial increases were seen in the 24-hour free hemoglobin and free heme in the NS-washed longer-storage RBC (43% and 58%, respectively). In the PL-A-washed RBC, in contrast, the 24-hour free hemoglobin and free heme levels were only slightly higher than baseline in the longer-storage RBC (11% and 15%, respectively). These increases in hemolysis were significantly smaller than NS-washed longer-storage RBC units (P = .024 and .012, respectively). Similar patterns were seen in the 48-and 72-hour RBC (Tables 2 and 3) .
Plasma-Lyte A Preserves Platelet Function as Compared With Saline
The baseline platelet count was 1,478 ± 257 × 10 9 /L (mean ± SD). Following washing, the platelet count dropped by about 5% in both groups (1,413 ± 185 × 10 9 /L; P > .05), demonstrating that the type of washing solution had no influence on platelet recovery. As stored platelets exhibit minimal to no platelet aggregation with single agonists, 30, 31 A representative example of PRP platelet aggregation in response to ADP (10 µmol/L) and epinephrine (10 µmol/L) at time 0 and collagen (2 µg/mL) at 10 minutes is shown in ❚Figure 2❚. While platelet aggregation of two washed PCs with PL-A (traces 3 and 4) were above 50% for both units, washing the same PC units with NS (traces 1 and 2) showed no measurable platelet aggregation (0%) for both units.
Plasma-Lyte A Improves Platelet Spreading as Compared With Normal Saline
As shown in ❚Figure 3C❚, higher percentages of partially and fully spread platelets were seen when PCs were washed with PL-A as compared with NS (P < .001). The highest percentage of platelets adhering to the fibrinogen coverslip but failing to spread were seen in both stored and fresh platelet samples after washing with NS. The highest percentages of fully spread platelets were observed in fresh PRP samples washed with PL-A (P < .001; Figure 3C ). 
Discussion
RBCs stored for 10 to 39 days and then washed with PL-A experience strikingly less hemolysis during shortterm postwashing storage compared with those washed and stored in NS. Whether or not similar degrees of hemolysis would occur in vivo after transfusion is not known. Less hemolysis was observed in the PL-A-washed RBCs stored for more than 4 weeks. We speculate this is due to the improved membrane stability of the longer-stored RBCs washed with PL-A. Although 48 to 72-hour storage of washed RBCs is not clinically employed at present in our center, we evaluated these two time points to measure differences between washing solutions at longer storage intervals. Hemolysis after NS as compared with PL-A washing became progressively worse as postwash storage continued. PL-A washing led to improved postwash platelet aggregation and spreading as compared to NS. Whether such differences would occur in vivo is not known, and the clinical implications are yet to be determined.
Reducing free hemoglobin and heme may be important in improving outcomes in transfused patients. Circulating free hemoglobin and heme levels have been associated with thrombosis in animal models, 32 transfused patients, and patients with sickle cell disease. 33, 34 NS, as opposed to PL-A, has been linked to increased renal injury and mortality in animal models and patients. 35, 36 More physiological levels of potassium and sodium were also reported in RBC washed with Plasma-Lyte as compared to NS washed RBC using the same washing device. 37 We speculate that hemolysis may be a contributory cause. Our results indicate that washing RBC with PL-A is a superior approach for maintaining RBC integrity and thus potentially safer than NS. These findings support further investigation of whether NS is truly a suitable diluent for RBC transfusion. PL-A washing might also facilitate lengthening the permissible storage period of washed RBCs.
In addition to removing most of the metabolic products and mediators that accumulate during storage, the results of our study confirm that washing blood products with PL-A better maintained RBC structural integrity and preserved platelet function as compared to the commonly used washing solution, NS. The remarkable differences in free heme and hemoglobin concentrations detected in the shorter versus longer stored RBCs washed with NS versus PL-A are additional evidence of the protective effect of PL-A on RBC integrity. PL-A also has potential to partially reverse storage-induced platelet dysfunction. This effect was specific to PL-A in both platelet aggregation and platelet spreading assays, because it was not seen when stored platelets were treated with NS (Figure 2 and Figure 3C ). Even when washed platelets were resuspended in ABO-identical plasma, platelet function tests were significantly better in the PL-A-washed platelet arm. Of note, PL-A is almost twice as expensive as NS; the additional cost per liter is approximately $1.00.
There are, to our knowledge, no other studies examining the effects of saline vs balanced salt solution washing on RBC lysis and platelet function. Our findings are thus novel. These in vitro studies are at present of unknown clinical relevance. Nonetheless, a growing body of data suggest that free hemoglobin, heme, and nontransferrin-bound iron can mediate morbidity and mortality in animal models. 38, 39 Our new data support the suggestion that further studies are warranted to determine whether PL-A (or similar balanced crystalloid solutions) has clinical outcome benefits compared to NS when used for resuscitation, coadministration with RBCs and platelets, apheresis, and cell washing in patients requiring crystalloid infusion or transfusion.
